References
- Franceschi S, Barra S, Vecchia C, Bidoli E, Negri E, and Talamini R. Risk factors for cancer of the tongue and the mouth. A case control study from northern Italy. Cancer 1992;70:2227-2233 https://doi.org/10.1002/1097-0142(19921101)70:9<2227::AID-CNCR2820700902>3.0.CO;2-Z
- Field JK, Kiaris H, Risk JM, et al. Allelotype of squamous cell carcinoma of the head and neck fractional allele loss correlates with survival. Br J Cancer 1995;72:1180-1188 https://doi.org/10.1038/bjc.1995.483
- Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994;16;86:265-272
- Pignon JP, Bourhis J, Domenge C, and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;18;355:949-955
- Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;3;88:890-899
- Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 13;324(24): 1685-1690
- Zaffaroni N, Silvestrini R, Orlandi L, Bearzatto A, Gornati D, and Villa R. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. Br J Cancer. 1998;77:1378-1385 https://doi.org/10.1038/bjc.1998.230
- Park JS, Yoon SY, Kim JM, Yeom YI, Kim YS, and Kim NS. Identificatin of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray. Cancer Lett. 2004;214:19-23 https://doi.org/10.1016/j.canlet.2004.04.012
- Buttitta F, Marchetti A, Gadducci A, et al. p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer. 1997;75:230-235 https://doi.org/10.1038/bjc.1997.38
- Righetti SC, Della Torre G, Pilotti S, et al. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Cancer Res. 1996; 15;56:689-693
- Bergh J, Norberg T, Sjogren S, Lindgren A, and Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1995;1:1029-1034 https://doi.org/10.1038/nm1095-1029
- Sanchez Y, Bachant J, Wang H, et al. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science. 1999; 5;286:1166-1171
- Wakasugi M, and Sancar A. Order of assembly of human DNA repair excision nuclease. J Biol Chem. 1999;274:18759-18768 https://doi.org/10.1074/jbc.274.26.18759
- Batty DP, and Wood RD. Damage recognition in nucleotide excision repair of DNA. Gene. 2000;241:193-204 https://doi.org/10.1016/S0378-1119(99)00489-8
- Zou L, and Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300:1542-1548 https://doi.org/10.1126/science.1083430
- Wang G, Dombkowski A, Chuang L, Xin S, and XU X. The involvement of XPC protein in the cisplatin DNA damaging treatment mediated cellular response. Cell Res. 2004;14:303-314 https://doi.org/10.1038/sj.cr.7290375
- Smith WL, DeWitt DL, and Garavito RM, Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69:145–182
- Williams CS, Mann M, and DuBois RN, The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908–7916
- Kim YB, Kim GE, Pyo HR, et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Clin Invest 2004;60:822-829
- Kim SA, Ahn SG, Kim DK, et al. Sequential expression of inducible nitric oxide synthase and cyclooxygenase-2 during DMBA-induced hamster buccal pouch carcinogenesis. In Vivo. 2004;18: 609-614
- Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, and Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 1994;54: 380-385
- Tahara E. Genetic alterations in human gastrointestinal cancers. Cancer(suppl.) 1995;75:1410-1417 https://doi.org/10.1002/1097-0142(19950315)75:6+<1410::AID-CNCR2820751504>3.0.CO;2-O
- Akama Y, Yasui W, Kuniyasu H, et al. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res. 1996;87:824-830 https://doi.org/10.1111/j.1349-7006.1996.tb02106.x
-
Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators
$p27^{Kip1}$ and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997;3:222-225 https://doi.org/10.1038/nm0297-222 - Robbins BA, de la Vega D, Ogata K, Tan EM, and Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med. 1987;111:841-845
- Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990 Dec;162:285-294 https://doi.org/10.1002/path.1711620403
- Counter CM, Hirte HW. Bacchetti S, and Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl acad Sci USA. 1994;91:2900-2904
- Counter CM, Gupta J, Harley CB, Leber B, and Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320
- Fujimoro r, Kamata N, Taki M, et al. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Oral Oncolo. 2003;39:445-452 https://doi.org/10.1016/S1368-8375(03)00003-4
- Culhaci N, Metin K, Copcu E, and Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinoma may reflect increased tumor invasiveness. BMC Caner. 2004;4:42 https://doi.org/10.1186/1471-2407-4-42
- Robinson CM, Stone AM, Shields JD, et al Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Arch Oral Biol 2003;48:779-786 https://doi.org/10.1016/S0003-9969(03)00172-9
- Richard CKJ, Maricris M, Caroline HS, et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res. 2004;10: 6460-6465 https://doi.org/10.1158/1078-0432.CCR-04-0656
- Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, and Stetler-Stevenson WG. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis. 2000 ;6:376-382 https://doi.org/10.1111/j.1601-0825.2000.tb00130.x